Alphabet announced Google-powered smartwatches will be able to access Gemini AI, starting today. Full rollout across devices could take a few weeks. Alphabet has been spending heavily on AI ...

Alphabet announced Google-powered smartwatches will be able to access Gemini AI, starting today. Full rollout across devices could take a few weeks. Alphabet has been spending heavily on AI ...

Financial giants have made a conspicuous bearish move on Alphabet. Our analysis of options history for Alphabet GOOGL revealed 20 unusual trades. Delving into the details, we found 25% of traders ...

Alphabet Inc. (NASDAQ:GOOGL) is one of the Top 10 Stocks to Buy According to Lakehouse Capital. The company’s investments in AI technologies position it well to capitalize on the upcoming wave ...

Alphabet announced Google-powered smartwatches will be able to access Gemini AI, starting today. Full rollout across devices could take a few weeks. Alphabet has been spending heavily on AI ...

The stock market cares more about future earnings potential than the past -- and that may be why Nvidia, Microsoft, Apple (NASDAQ: AAPL), and Amazon (NASDAQ: AMZN) are all worth more than Alphabet ...

Google’s AI tools will help Alphabet stay competitive, Citizens JMP says. BNP Paribas Exane says all hyperscalers are challenged.

To me, the deal with OpenAI is a transformative game changer for Alphabet in the long run and I see the stock as a no-brainer buy right now. Should you invest $1,000 in Alphabet right now?

Squali anticipates continued growth across Alphabet’s business units, which include search. This is despite investor concerns over Alphabet’s search future as new artificial intelligence tools ...

I think Alphabet can deliver shareholders monster returns over the next two years through a combination of a few factors.

Since Alphabet has not traded at such a deep discount to the market for so long, I believe that now is a once-in-a-decade opportunity to pick up Alphabet shares at an extremely attractive price.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.